4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0000905148-24-002244
Options or other derivatives
- President and CEO returned 25,755 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
Touchon Pascal · President and CEO
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-08-12 | Returned to the company : show line 1 in the form Employee Stock Option (Right to Buy) | −9,000 | 0 | D |
| 2024-08-12 | Returned to the company : show line 2 in the form Employee Stock Option (Right to Buy) | −9,680 | 0 | D |
| 2024-08-12 | Returned to the company : show line 3 in the form Employee Stock Option (Right to Buy) | −7,075 | 0 | D |
Loading xslF345X05/form4.xml…